Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Fatih Kocabas
Introduction
Fatih Kocabas is a notable inventor based in Istanbul, Turkey. He has made significant contributions to the field of biomedical research, particularly in the area of hematopoietic stem cell proliferation. His innovative work has led to the development of a unique composition that inhibits MEIS proteins, which play a crucial role in stem cell biology.
Latest Patents
Kocabas holds a patent for a composition that inhibits MEIS proteins. This formulation is designed to easily pass through cell membranes and perform its activity within the cell. It can inhibit MEIS activity in a dose-dependent manner. The combination includes isolated cells from mouse bone marrow, human bone marrow, and human umbilical cord blood, along with a medium that has a pH value of 7.2. This medium contains bovine serum albumin, recombinant insulin, transferrin, 2-mercaptoethanol, and IMDM medium. The growth factors involved are hematopoietic stem cell factor SCF, fetus liver tyrosine kinase-3 ligand Flt3L, and thrombopoietin. The chemical formulas for the MEIS inhibitors are also noteworthy, with MEISi-1 being 4-[2-(benzylamino)-2-oxoethoxy]-N-(2,3-dimethylphenyl) benzamide and MEISi-2 being 4-hydroxy-N'-[(Z)-(2-oxonaphthalen-1-ylidene)methyl] benzohydrazide.
Career Highlights
Throughout his career, Fatih Kocabas has worked with esteemed institutions, including Yeditepe University. His research has focused on enhancing the understanding of stem cell biology and developing innovative solutions for medical applications.
Collaborations
Kocabas has collaborated with various professionals in his field, including Raife Dilek Turan. These collaborations have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Fatih Kocabas is a prominent inventor whose work in inhibiting MEIS proteins has the potential to significantly impact the field of stem cell research. His innovative contributions continue to pave the way for advancements in biomedical applications.